Global Multi-disease Fundus Imaging-assisted Diagnostic System Supply, Demand and Key Producers, 2026-2032
The global Multi-disease Fundus Imaging-assisted Diagnostic System market size is expected to reach $ 3344 million by 2032, rising at a market growth of 8.3% CAGR during the forecast period (2026-2032).
Multi-disease Fundus Imaging-assisted Diagnostic System refers to medical software that uses artificial intelligence technology, especially deep learning algorithms, to automatically analyze eye images, enabling early detection of eye diseases, assisted diagnosis, and health risk assessment. This type of software can quickly identify characteristics of various eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Its core value lies in improving screening efficiency and consistency, assisting doctors in making judgments, and helping to extend high-quality ophthalmological diagnostic capabilities to resource-scarce areas.
Multi-disease Fundus Imaging-assisted Diagnostic System has a promising future and is at a critical stage of evolution from 'single-disease assisted detection' to 'comprehensive multi-disease assessment and systemic health early warning.' The market growth drivers are clear: the increase in the global diabetic population and the aging population has driven up the rigid demand for early eye disease screening; continuous advancements in deep learning technology have improved the accuracy and reliability of algorithms; and supportive regulatory policies and exploration of medical insurance reimbursement are accelerating its clinical implementation. In the future, this field will exhibit three major trends: First, technological integration, which will be combined with portable devices and telemedicine platforms to expand screening scenarios from hospitals to grassroots communities and even homes; second, functional diversification, extending from single eye disease screening to predicting disease progression and assessing overall health; and third, ecosystem systematization, integrating into the closed loop of 'prevention-screening-diagnosis-management' and becoming an important digital infrastructure for eye health and even chronic disease management systems.
This report studies the global Multi-disease Fundus Imaging-assisted Diagnostic System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multi-disease Fundus Imaging-assisted Diagnostic System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multi-disease Fundus Imaging-assisted Diagnostic System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market, 2021-2032, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Multi-disease Fundus Imaging-assisted Diagnostic System total market, key domestic companies, and share, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System revenue by player, revenue and market share 2021-2026, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market by Type, CAGR, 2021-2032, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Multi-disease Fundus Imaging-assisted Diagnostic System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AEYE Health, RetinaLyze, DeepMind, Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Synapxe, Intelligent Retinal Imaging Systems, Retmarker, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Multi-disease Fundus Imaging-assisted Diagnostic System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Multi-disease Fundus Imaging-assisted Diagnostic System Market, By Region:
1. How big is the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
2. What is the demand of the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
3. What is the year over year growth of the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
4. What is the total value of the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
5. Who are the Major Players in the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
6. What are the growth factors driving the market demand?
Multi-disease Fundus Imaging-assisted Diagnostic System refers to medical software that uses artificial intelligence technology, especially deep learning algorithms, to automatically analyze eye images, enabling early detection of eye diseases, assisted diagnosis, and health risk assessment. This type of software can quickly identify characteristics of various eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Its core value lies in improving screening efficiency and consistency, assisting doctors in making judgments, and helping to extend high-quality ophthalmological diagnostic capabilities to resource-scarce areas.
Multi-disease Fundus Imaging-assisted Diagnostic System has a promising future and is at a critical stage of evolution from 'single-disease assisted detection' to 'comprehensive multi-disease assessment and systemic health early warning.' The market growth drivers are clear: the increase in the global diabetic population and the aging population has driven up the rigid demand for early eye disease screening; continuous advancements in deep learning technology have improved the accuracy and reliability of algorithms; and supportive regulatory policies and exploration of medical insurance reimbursement are accelerating its clinical implementation. In the future, this field will exhibit three major trends: First, technological integration, which will be combined with portable devices and telemedicine platforms to expand screening scenarios from hospitals to grassroots communities and even homes; second, functional diversification, extending from single eye disease screening to predicting disease progression and assessing overall health; and third, ecosystem systematization, integrating into the closed loop of 'prevention-screening-diagnosis-management' and becoming an important digital infrastructure for eye health and even chronic disease management systems.
This report studies the global Multi-disease Fundus Imaging-assisted Diagnostic System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multi-disease Fundus Imaging-assisted Diagnostic System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multi-disease Fundus Imaging-assisted Diagnostic System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market, 2021-2032, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Multi-disease Fundus Imaging-assisted Diagnostic System total market, key domestic companies, and share, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System revenue by player, revenue and market share 2021-2026, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market by Type, CAGR, 2021-2032, (USD Million)
Global Multi-disease Fundus Imaging-assisted Diagnostic System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Multi-disease Fundus Imaging-assisted Diagnostic System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AEYE Health, RetinaLyze, DeepMind, Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Synapxe, Intelligent Retinal Imaging Systems, Retmarker, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Multi-disease Fundus Imaging-assisted Diagnostic System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Multi-disease Fundus Imaging-assisted Diagnostic System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- On-premise
- Cloud-based
- AI Based on Fundus Images
- AI Based on OCT
- Disease Screening and Assisted Diagnosis Software
- Systemic Health Risk Assessment Software
- Embedded System Integrated into Professional Equipment
- SaaS Service Based on Cloud Platform
- Mobile/Portable Applications
- Hospitals
- Clinics
- AEYE Health
- RetinaLyze
- DeepMind
- Remidio
- RetinAI
- RetinaRisk
- Eyenuk, Inc.
- Synapxe
- Intelligent Retinal Imaging Systems
- Retmarker
- CSIRO
- WeDoctor Group
- VoxelCloud
- Zhenhealth
- Tencent Health
- Airdoc
- Silicon Intelligence
- Zhiyuan Huitu
- Kangfuzi Health
1. How big is the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
2. What is the demand of the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
3. What is the year over year growth of the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
4. What is the total value of the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
5. Who are the Major Players in the global Multi-disease Fundus Imaging-assisted Diagnostic System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Multi-disease Fundus Imaging-assisted Diagnostic System Introduction
1.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Total Market by Region (by Headquarter Location)
1.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.3 China Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.4 Europe Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.5 Japan Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.6 South Korea Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.7 ASEAN Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.8 India Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region
2.2.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2026)
2.2.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Forecast by Region (2027-2032)
2.3 United States Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.4 China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.5 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.6 Japan Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.7 South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.8 ASEAN Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.9 India Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
3 WORLD MULTI-DISEASE FUNDUS IMAGING-ASSISTED DIAGNOSTIC SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Multi-disease Fundus Imaging-assisted Diagnostic System in 2025
3.2.3 Global Concentration Ratios (CR8) for Multi-disease Fundus Imaging-assisted Diagnostic System in 2025
3.3 Multi-disease Fundus Imaging-assisted Diagnostic System Company Evaluation Quadrant
3.4 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Overall Company Footprint Analysis
3.4.1 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Region Footprint
3.4.2 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Type Footprint
3.4.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Comparison
4.2.1 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies and Market Share, 2021-2026
4.3.1 United States Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026)
4.4 China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Market Share, 2021-2026
4.4.1 China Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026)
4.5 Rest of World Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 On-premise
5.2.2 Cloud-based
5.3 Market Segment by Type
5.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2021-2026)
5.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2027-2032)
5.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY/IMAGING FUNDAMENTALS
6.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Technology/Imaging Fundamentals: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology/Imaging Fundamentals
6.2.1 AI Based on Fundus Images
6.2.2 AI Based on OCT
6.3 Market Segment by Technology/Imaging Fundamentals
6.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals (2021-2026)
6.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals (2027-2032)
6.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Technology/Imaging Fundamentals (2027-2032)
7 MARKET ANALYSIS BY CORE FUNCTIONS
7.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Core Functions: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Core Functions
7.2.1 Disease Screening and Assisted Diagnosis Software
7.2.2 Systemic Health Risk Assessment Software
7.3 Market Segment by Core Functions
7.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions (2021-2026)
7.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions (2027-2032)
7.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Core Functions (2027-2032)
8 MARKET ANALYSIS BY DEPLOYMENT AND USAGE MODES
8.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Deployment and Usage Modes: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Deployment and Usage Modes
8.2.1 Embedded System Integrated into Professional Equipment
8.2.2 SaaS Service Based on Cloud Platform
8.2.3 Mobile/Portable Applications
8.3 Market Segment by Deployment and Usage Modes
8.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes (2021-2026)
8.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes (2027-2032)
8.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Deployment and Usage Modes (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Hospitals
9.2.2 Clinics
9.3 Market Segment by Application
9.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2026)
9.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2027-2032)
9.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 AEYE Health
10.1.1 AEYE Health Details
10.1.2 AEYE Health Major Business
10.1.3 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.1.4 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 AEYE Health Recent Developments/Updates
10.1.6 AEYE Health Competitive Strengths & Weaknesses
10.2 RetinaLyze
10.2.1 RetinaLyze Details
10.2.2 RetinaLyze Major Business
10.2.3 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.2.4 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 RetinaLyze Recent Developments/Updates
10.2.6 RetinaLyze Competitive Strengths & Weaknesses
10.3 DeepMind
10.3.1 DeepMind Details
10.3.2 DeepMind Major Business
10.3.3 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.3.4 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 DeepMind Recent Developments/Updates
10.3.6 DeepMind Competitive Strengths & Weaknesses
10.4 Remidio
10.4.1 Remidio Details
10.4.2 Remidio Major Business
10.4.3 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.4.4 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Remidio Recent Developments/Updates
10.4.6 Remidio Competitive Strengths & Weaknesses
10.5 RetinAI
10.5.1 RetinAI Details
10.5.2 RetinAI Major Business
10.5.3 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.5.4 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 RetinAI Recent Developments/Updates
10.5.6 RetinAI Competitive Strengths & Weaknesses
10.6 RetinaRisk
10.6.1 RetinaRisk Details
10.6.2 RetinaRisk Major Business
10.6.3 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.6.4 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 RetinaRisk Recent Developments/Updates
10.6.6 RetinaRisk Competitive Strengths & Weaknesses
10.7 Eyenuk, Inc.
10.7.1 Eyenuk, Inc. Details
10.7.2 Eyenuk, Inc. Major Business
10.7.3 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.7.4 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Eyenuk, Inc. Recent Developments/Updates
10.7.6 Eyenuk, Inc. Competitive Strengths & Weaknesses
10.8 Synapxe
10.8.1 Synapxe Details
10.8.2 Synapxe Major Business
10.8.3 Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.8.4 Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Synapxe Recent Developments/Updates
10.8.6 Synapxe Competitive Strengths & Weaknesses
10.9 Intelligent Retinal Imaging Systems
10.9.1 Intelligent Retinal Imaging Systems Details
10.9.2 Intelligent Retinal Imaging Systems Major Business
10.9.3 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.9.4 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Intelligent Retinal Imaging Systems Recent Developments/Updates
10.9.6 Intelligent Retinal Imaging Systems Competitive Strengths & Weaknesses
10.10 Retmarker
10.10.1 Retmarker Details
10.10.2 Retmarker Major Business
10.10.3 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.10.4 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Retmarker Recent Developments/Updates
10.10.6 Retmarker Competitive Strengths & Weaknesses
10.11 CSIRO
10.11.1 CSIRO Details
10.11.2 CSIRO Major Business
10.11.3 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.11.4 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 CSIRO Recent Developments/Updates
10.11.6 CSIRO Competitive Strengths & Weaknesses
10.12 WeDoctor Group
10.12.1 WeDoctor Group Details
10.12.2 WeDoctor Group Major Business
10.12.3 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.12.4 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 WeDoctor Group Recent Developments/Updates
10.12.6 WeDoctor Group Competitive Strengths & Weaknesses
10.13 VoxelCloud
10.13.1 VoxelCloud Details
10.13.2 VoxelCloud Major Business
10.13.3 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.13.4 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 VoxelCloud Recent Developments/Updates
10.13.6 VoxelCloud Competitive Strengths & Weaknesses
10.14 Zhenhealth
10.14.1 Zhenhealth Details
10.14.2 Zhenhealth Major Business
10.14.3 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.14.4 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Zhenhealth Recent Developments/Updates
10.14.6 Zhenhealth Competitive Strengths & Weaknesses
10.15 Tencent Health
10.15.1 Tencent Health Details
10.15.2 Tencent Health Major Business
10.15.3 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.15.4 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 Tencent Health Recent Developments/Updates
10.15.6 Tencent Health Competitive Strengths & Weaknesses
10.16 Airdoc
10.16.1 Airdoc Details
10.16.2 Airdoc Major Business
10.16.3 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.16.4 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.16.5 Airdoc Recent Developments/Updates
10.16.6 Airdoc Competitive Strengths & Weaknesses
10.17 Silicon Intelligence
10.17.1 Silicon Intelligence Details
10.17.2 Silicon Intelligence Major Business
10.17.3 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.17.4 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.17.5 Silicon Intelligence Recent Developments/Updates
10.17.6 Silicon Intelligence Competitive Strengths & Weaknesses
10.18 Zhiyuan Huitu
10.18.1 Zhiyuan Huitu Details
10.18.2 Zhiyuan Huitu Major Business
10.18.3 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.18.4 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.18.5 Zhiyuan Huitu Recent Developments/Updates
10.18.6 Zhiyuan Huitu Competitive Strengths & Weaknesses
10.19 Kangfuzi Health
10.19.1 Kangfuzi Health Details
10.19.2 Kangfuzi Health Major Business
10.19.3 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.19.4 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.19.5 Kangfuzi Health Recent Developments/Updates
10.19.6 Kangfuzi Health Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Chain
11.2 Multi-disease Fundus Imaging-assisted Diagnostic System Upstream Analysis
11.3 Multi-disease Fundus Imaging-assisted Diagnostic System Midstream Analysis
11.4 Multi-disease Fundus Imaging-assisted Diagnostic System Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Multi-disease Fundus Imaging-assisted Diagnostic System Introduction
1.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Total Market by Region (by Headquarter Location)
1.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.3 China Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.4 Europe Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.5 Japan Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.6 South Korea Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.7 ASEAN Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.3.8 India Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region
2.2.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2026)
2.2.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Forecast by Region (2027-2032)
2.3 United States Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.4 China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.5 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.6 Japan Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.7 South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.8 ASEAN Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
2.9 India Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032)
3 WORLD MULTI-DISEASE FUNDUS IMAGING-ASSISTED DIAGNOSTIC SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Multi-disease Fundus Imaging-assisted Diagnostic System in 2025
3.2.3 Global Concentration Ratios (CR8) for Multi-disease Fundus Imaging-assisted Diagnostic System in 2025
3.3 Multi-disease Fundus Imaging-assisted Diagnostic System Company Evaluation Quadrant
3.4 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Overall Company Footprint Analysis
3.4.1 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Region Footprint
3.4.2 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Type Footprint
3.4.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Comparison
4.2.1 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies and Market Share, 2021-2026
4.3.1 United States Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026)
4.4 China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Market Share, 2021-2026
4.4.1 China Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026)
4.5 Rest of World Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 On-premise
5.2.2 Cloud-based
5.3 Market Segment by Type
5.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2021-2026)
5.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2027-2032)
5.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY/IMAGING FUNDAMENTALS
6.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Technology/Imaging Fundamentals: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology/Imaging Fundamentals
6.2.1 AI Based on Fundus Images
6.2.2 AI Based on OCT
6.3 Market Segment by Technology/Imaging Fundamentals
6.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals (2021-2026)
6.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals (2027-2032)
6.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Technology/Imaging Fundamentals (2027-2032)
7 MARKET ANALYSIS BY CORE FUNCTIONS
7.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Core Functions: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Core Functions
7.2.1 Disease Screening and Assisted Diagnosis Software
7.2.2 Systemic Health Risk Assessment Software
7.3 Market Segment by Core Functions
7.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions (2021-2026)
7.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions (2027-2032)
7.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Core Functions (2027-2032)
8 MARKET ANALYSIS BY DEPLOYMENT AND USAGE MODES
8.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Deployment and Usage Modes: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Deployment and Usage Modes
8.2.1 Embedded System Integrated into Professional Equipment
8.2.2 SaaS Service Based on Cloud Platform
8.2.3 Mobile/Portable Applications
8.3 Market Segment by Deployment and Usage Modes
8.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes (2021-2026)
8.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes (2027-2032)
8.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Deployment and Usage Modes (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Hospitals
9.2.2 Clinics
9.3 Market Segment by Application
9.3.1 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2026)
9.3.2 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2027-2032)
9.3.3 World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 AEYE Health
10.1.1 AEYE Health Details
10.1.2 AEYE Health Major Business
10.1.3 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.1.4 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 AEYE Health Recent Developments/Updates
10.1.6 AEYE Health Competitive Strengths & Weaknesses
10.2 RetinaLyze
10.2.1 RetinaLyze Details
10.2.2 RetinaLyze Major Business
10.2.3 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.2.4 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 RetinaLyze Recent Developments/Updates
10.2.6 RetinaLyze Competitive Strengths & Weaknesses
10.3 DeepMind
10.3.1 DeepMind Details
10.3.2 DeepMind Major Business
10.3.3 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.3.4 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 DeepMind Recent Developments/Updates
10.3.6 DeepMind Competitive Strengths & Weaknesses
10.4 Remidio
10.4.1 Remidio Details
10.4.2 Remidio Major Business
10.4.3 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.4.4 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Remidio Recent Developments/Updates
10.4.6 Remidio Competitive Strengths & Weaknesses
10.5 RetinAI
10.5.1 RetinAI Details
10.5.2 RetinAI Major Business
10.5.3 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.5.4 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 RetinAI Recent Developments/Updates
10.5.6 RetinAI Competitive Strengths & Weaknesses
10.6 RetinaRisk
10.6.1 RetinaRisk Details
10.6.2 RetinaRisk Major Business
10.6.3 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.6.4 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 RetinaRisk Recent Developments/Updates
10.6.6 RetinaRisk Competitive Strengths & Weaknesses
10.7 Eyenuk, Inc.
10.7.1 Eyenuk, Inc. Details
10.7.2 Eyenuk, Inc. Major Business
10.7.3 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.7.4 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Eyenuk, Inc. Recent Developments/Updates
10.7.6 Eyenuk, Inc. Competitive Strengths & Weaknesses
10.8 Synapxe
10.8.1 Synapxe Details
10.8.2 Synapxe Major Business
10.8.3 Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.8.4 Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Synapxe Recent Developments/Updates
10.8.6 Synapxe Competitive Strengths & Weaknesses
10.9 Intelligent Retinal Imaging Systems
10.9.1 Intelligent Retinal Imaging Systems Details
10.9.2 Intelligent Retinal Imaging Systems Major Business
10.9.3 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.9.4 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Intelligent Retinal Imaging Systems Recent Developments/Updates
10.9.6 Intelligent Retinal Imaging Systems Competitive Strengths & Weaknesses
10.10 Retmarker
10.10.1 Retmarker Details
10.10.2 Retmarker Major Business
10.10.3 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.10.4 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Retmarker Recent Developments/Updates
10.10.6 Retmarker Competitive Strengths & Weaknesses
10.11 CSIRO
10.11.1 CSIRO Details
10.11.2 CSIRO Major Business
10.11.3 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.11.4 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 CSIRO Recent Developments/Updates
10.11.6 CSIRO Competitive Strengths & Weaknesses
10.12 WeDoctor Group
10.12.1 WeDoctor Group Details
10.12.2 WeDoctor Group Major Business
10.12.3 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.12.4 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 WeDoctor Group Recent Developments/Updates
10.12.6 WeDoctor Group Competitive Strengths & Weaknesses
10.13 VoxelCloud
10.13.1 VoxelCloud Details
10.13.2 VoxelCloud Major Business
10.13.3 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.13.4 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 VoxelCloud Recent Developments/Updates
10.13.6 VoxelCloud Competitive Strengths & Weaknesses
10.14 Zhenhealth
10.14.1 Zhenhealth Details
10.14.2 Zhenhealth Major Business
10.14.3 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.14.4 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Zhenhealth Recent Developments/Updates
10.14.6 Zhenhealth Competitive Strengths & Weaknesses
10.15 Tencent Health
10.15.1 Tencent Health Details
10.15.2 Tencent Health Major Business
10.15.3 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.15.4 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 Tencent Health Recent Developments/Updates
10.15.6 Tencent Health Competitive Strengths & Weaknesses
10.16 Airdoc
10.16.1 Airdoc Details
10.16.2 Airdoc Major Business
10.16.3 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.16.4 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.16.5 Airdoc Recent Developments/Updates
10.16.6 Airdoc Competitive Strengths & Weaknesses
10.17 Silicon Intelligence
10.17.1 Silicon Intelligence Details
10.17.2 Silicon Intelligence Major Business
10.17.3 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.17.4 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.17.5 Silicon Intelligence Recent Developments/Updates
10.17.6 Silicon Intelligence Competitive Strengths & Weaknesses
10.18 Zhiyuan Huitu
10.18.1 Zhiyuan Huitu Details
10.18.2 Zhiyuan Huitu Major Business
10.18.3 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.18.4 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.18.5 Zhiyuan Huitu Recent Developments/Updates
10.18.6 Zhiyuan Huitu Competitive Strengths & Weaknesses
10.19 Kangfuzi Health
10.19.1 Kangfuzi Health Details
10.19.2 Kangfuzi Health Major Business
10.19.3 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
10.19.4 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
10.19.5 Kangfuzi Health Recent Developments/Updates
10.19.6 Kangfuzi Health Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Chain
11.2 Multi-disease Fundus Imaging-assisted Diagnostic System Upstream Analysis
11.3 Multi-disease Fundus Imaging-assisted Diagnostic System Midstream Analysis
11.4 Multi-disease Fundus Imaging-assisted Diagnostic System Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Multi-disease Fundus Imaging-assisted Diagnostic System Players in 2025
Table 12. World Multi-disease Fundus Imaging-assisted Diagnostic System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Evaluation Quadrant
Table 14. Head Office of Key Multi-disease Fundus Imaging-assisted Diagnostic System Players
Table 15. Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Type Footprint
Table 16. Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Application Footprint
Table 17. Multi-disease Fundus Imaging-assisted Diagnostic System Mergers & Acquisitions Activity
Table 18. United States VS China Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share (2021-2026)
Table 23. China Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share (2021-2026)
Table 26. Rest of World Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share (2021-2026)
Table 29. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2027-2032) & (USD Million)
Table 32. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals, (USD Million), 2021 & 2025 & 2032
Table 33. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Technology/Imaging Fundamentals (2021-2026) & (USD Million)
Table 34. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals (2027-2032) & (USD Million)
Table 35. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions, (USD Million), 2021 & 2025 & 2032
Table 36. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Core Functions (2021-2026) & (USD Million)
Table 37. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions (2027-2032) & (USD Million)
Table 38. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes, (USD Million), 2021 & 2025 & 2032
Table 39. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Deployment and Usage Modes (2021-2026) & (USD Million)
Table 40. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes (2027-2032) & (USD Million)
Table 41. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2026) & (USD Million)
Table 43. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2027-2032) & (USD Million)
Table 44. AEYE Health Basic Information, Manufacturing Base and Competitors
Table 45. AEYE Health Major Business
Table 46. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 47. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. AEYE Health Recent Developments/Updates
Table 49. AEYE Health Competitive Strengths & Weaknesses
Table 50. RetinaLyze Basic Information, Manufacturing Base and Competitors
Table 51. RetinaLyze Major Business
Table 52. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 53. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. RetinaLyze Recent Developments/Updates
Table 55. RetinaLyze Competitive Strengths & Weaknesses
Table 56. DeepMind Basic Information, Manufacturing Base and Competitors
Table 57. DeepMind Major Business
Table 58. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 59. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. DeepMind Recent Developments/Updates
Table 61. DeepMind Competitive Strengths & Weaknesses
Table 62. Remidio Basic Information, Manufacturing Base and Competitors
Table 63. Remidio Major Business
Table 64. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 65. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Remidio Recent Developments/Updates
Table 67. Remidio Competitive Strengths & Weaknesses
Table 68. RetinAI Basic Information, Manufacturing Base and Competitors
Table 69. RetinAI Major Business
Table 70. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 71. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. RetinAI Recent Developments/Updates
Table 73. RetinAI Competitive Strengths & Weaknesses
Table 74. RetinaRisk Basic Information, Manufacturing Base and Competitors
Table 75. RetinaRisk Major Business
Table 76. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 77. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. RetinaRisk Recent Developments/Updates
Table 79. RetinaRisk Competitive Strengths & Weaknesses
Table 80. Eyenuk, Inc. Basic Information, Manufacturing Base and Competitors
Table 81. Eyenuk, Inc. Major Business
Table 82. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 83. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Eyenuk, Inc. Recent Developments/Updates
Table 85. Eyenuk, Inc. Competitive Strengths & Weaknesses
Table 86. Synapxe Basic Information, Manufacturing Base and Competitors
Table 87. Synapxe Major Business
Table 88. Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 89. Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Synapxe Recent Developments/Updates
Table 91. Synapxe Competitive Strengths & Weaknesses
Table 92. Intelligent Retinal Imaging Systems Basic Information, Manufacturing Base and Competitors
Table 93. Intelligent Retinal Imaging Systems Major Business
Table 94. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 95. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Intelligent Retinal Imaging Systems Recent Developments/Updates
Table 97. Intelligent Retinal Imaging Systems Competitive Strengths & Weaknesses
Table 98. Retmarker Basic Information, Manufacturing Base and Competitors
Table 99. Retmarker Major Business
Table 100. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 101. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Retmarker Recent Developments/Updates
Table 103. Retmarker Competitive Strengths & Weaknesses
Table 104. CSIRO Basic Information, Manufacturing Base and Competitors
Table 105. CSIRO Major Business
Table 106. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 107. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. CSIRO Recent Developments/Updates
Table 109. CSIRO Competitive Strengths & Weaknesses
Table 110. WeDoctor Group Basic Information, Manufacturing Base and Competitors
Table 111. WeDoctor Group Major Business
Table 112. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 113. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. WeDoctor Group Recent Developments/Updates
Table 115. WeDoctor Group Competitive Strengths & Weaknesses
Table 116. VoxelCloud Basic Information, Manufacturing Base and Competitors
Table 117. VoxelCloud Major Business
Table 118. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 119. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. VoxelCloud Recent Developments/Updates
Table 121. VoxelCloud Competitive Strengths & Weaknesses
Table 122. Zhenhealth Basic Information, Manufacturing Base and Competitors
Table 123. Zhenhealth Major Business
Table 124. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 125. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Zhenhealth Recent Developments/Updates
Table 127. Zhenhealth Competitive Strengths & Weaknesses
Table 128. Tencent Health Basic Information, Manufacturing Base and Competitors
Table 129. Tencent Health Major Business
Table 130. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 131. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Tencent Health Recent Developments/Updates
Table 133. Tencent Health Competitive Strengths & Weaknesses
Table 134. Airdoc Basic Information, Manufacturing Base and Competitors
Table 135. Airdoc Major Business
Table 136. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 137. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Airdoc Recent Developments/Updates
Table 139. Airdoc Competitive Strengths & Weaknesses
Table 140. Silicon Intelligence Basic Information, Manufacturing Base and Competitors
Table 141. Silicon Intelligence Major Business
Table 142. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 143. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Silicon Intelligence Recent Developments/Updates
Table 145. Silicon Intelligence Competitive Strengths & Weaknesses
Table 146. Zhiyuan Huitu Basic Information, Manufacturing Base and Competitors
Table 147. Zhiyuan Huitu Major Business
Table 148. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 149. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Zhiyuan Huitu Recent Developments/Updates
Table 151. Zhiyuan Huitu Competitive Strengths & Weaknesses
Table 152. Kangfuzi Health Basic Information, Manufacturing Base and Competitors
Table 153. Kangfuzi Health Major Business
Table 154. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 155. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Kangfuzi Health Recent Developments/Updates
Table 157. Kangfuzi Health Competitive Strengths & Weaknesses
Table 158. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System Upstream (Raw Materials)
Table 159. Global Multi-disease Fundus Imaging-assisted Diagnostic System Typical Customers
Table 1. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Multi-disease Fundus Imaging-assisted Diagnostic System Players in 2025
Table 12. World Multi-disease Fundus Imaging-assisted Diagnostic System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Evaluation Quadrant
Table 14. Head Office of Key Multi-disease Fundus Imaging-assisted Diagnostic System Players
Table 15. Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Type Footprint
Table 16. Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Application Footprint
Table 17. Multi-disease Fundus Imaging-assisted Diagnostic System Mergers & Acquisitions Activity
Table 18. United States VS China Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share (2021-2026)
Table 23. China Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share (2021-2026)
Table 26. Rest of World Based Multi-disease Fundus Imaging-assisted Diagnostic System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share (2021-2026)
Table 29. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2027-2032) & (USD Million)
Table 32. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals, (USD Million), 2021 & 2025 & 2032
Table 33. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Technology/Imaging Fundamentals (2021-2026) & (USD Million)
Table 34. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals (2027-2032) & (USD Million)
Table 35. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions, (USD Million), 2021 & 2025 & 2032
Table 36. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Core Functions (2021-2026) & (USD Million)
Table 37. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions (2027-2032) & (USD Million)
Table 38. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes, (USD Million), 2021 & 2025 & 2032
Table 39. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Value by Deployment and Usage Modes (2021-2026) & (USD Million)
Table 40. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes (2027-2032) & (USD Million)
Table 41. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2026) & (USD Million)
Table 43. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2027-2032) & (USD Million)
Table 44. AEYE Health Basic Information, Manufacturing Base and Competitors
Table 45. AEYE Health Major Business
Table 46. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 47. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. AEYE Health Recent Developments/Updates
Table 49. AEYE Health Competitive Strengths & Weaknesses
Table 50. RetinaLyze Basic Information, Manufacturing Base and Competitors
Table 51. RetinaLyze Major Business
Table 52. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 53. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. RetinaLyze Recent Developments/Updates
Table 55. RetinaLyze Competitive Strengths & Weaknesses
Table 56. DeepMind Basic Information, Manufacturing Base and Competitors
Table 57. DeepMind Major Business
Table 58. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 59. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. DeepMind Recent Developments/Updates
Table 61. DeepMind Competitive Strengths & Weaknesses
Table 62. Remidio Basic Information, Manufacturing Base and Competitors
Table 63. Remidio Major Business
Table 64. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 65. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Remidio Recent Developments/Updates
Table 67. Remidio Competitive Strengths & Weaknesses
Table 68. RetinAI Basic Information, Manufacturing Base and Competitors
Table 69. RetinAI Major Business
Table 70. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 71. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. RetinAI Recent Developments/Updates
Table 73. RetinAI Competitive Strengths & Weaknesses
Table 74. RetinaRisk Basic Information, Manufacturing Base and Competitors
Table 75. RetinaRisk Major Business
Table 76. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 77. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. RetinaRisk Recent Developments/Updates
Table 79. RetinaRisk Competitive Strengths & Weaknesses
Table 80. Eyenuk, Inc. Basic Information, Manufacturing Base and Competitors
Table 81. Eyenuk, Inc. Major Business
Table 82. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 83. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Eyenuk, Inc. Recent Developments/Updates
Table 85. Eyenuk, Inc. Competitive Strengths & Weaknesses
Table 86. Synapxe Basic Information, Manufacturing Base and Competitors
Table 87. Synapxe Major Business
Table 88. Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 89. Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Synapxe Recent Developments/Updates
Table 91. Synapxe Competitive Strengths & Weaknesses
Table 92. Intelligent Retinal Imaging Systems Basic Information, Manufacturing Base and Competitors
Table 93. Intelligent Retinal Imaging Systems Major Business
Table 94. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 95. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Intelligent Retinal Imaging Systems Recent Developments/Updates
Table 97. Intelligent Retinal Imaging Systems Competitive Strengths & Weaknesses
Table 98. Retmarker Basic Information, Manufacturing Base and Competitors
Table 99. Retmarker Major Business
Table 100. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 101. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Retmarker Recent Developments/Updates
Table 103. Retmarker Competitive Strengths & Weaknesses
Table 104. CSIRO Basic Information, Manufacturing Base and Competitors
Table 105. CSIRO Major Business
Table 106. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 107. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. CSIRO Recent Developments/Updates
Table 109. CSIRO Competitive Strengths & Weaknesses
Table 110. WeDoctor Group Basic Information, Manufacturing Base and Competitors
Table 111. WeDoctor Group Major Business
Table 112. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 113. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. WeDoctor Group Recent Developments/Updates
Table 115. WeDoctor Group Competitive Strengths & Weaknesses
Table 116. VoxelCloud Basic Information, Manufacturing Base and Competitors
Table 117. VoxelCloud Major Business
Table 118. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 119. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. VoxelCloud Recent Developments/Updates
Table 121. VoxelCloud Competitive Strengths & Weaknesses
Table 122. Zhenhealth Basic Information, Manufacturing Base and Competitors
Table 123. Zhenhealth Major Business
Table 124. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 125. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Zhenhealth Recent Developments/Updates
Table 127. Zhenhealth Competitive Strengths & Weaknesses
Table 128. Tencent Health Basic Information, Manufacturing Base and Competitors
Table 129. Tencent Health Major Business
Table 130. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 131. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Tencent Health Recent Developments/Updates
Table 133. Tencent Health Competitive Strengths & Weaknesses
Table 134. Airdoc Basic Information, Manufacturing Base and Competitors
Table 135. Airdoc Major Business
Table 136. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 137. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Airdoc Recent Developments/Updates
Table 139. Airdoc Competitive Strengths & Weaknesses
Table 140. Silicon Intelligence Basic Information, Manufacturing Base and Competitors
Table 141. Silicon Intelligence Major Business
Table 142. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 143. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Silicon Intelligence Recent Developments/Updates
Table 145. Silicon Intelligence Competitive Strengths & Weaknesses
Table 146. Zhiyuan Huitu Basic Information, Manufacturing Base and Competitors
Table 147. Zhiyuan Huitu Major Business
Table 148. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 149. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Zhiyuan Huitu Recent Developments/Updates
Table 151. Zhiyuan Huitu Competitive Strengths & Weaknesses
Table 152. Kangfuzi Health Basic Information, Manufacturing Base and Competitors
Table 153. Kangfuzi Health Major Business
Table 154. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Services
Table 155. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Kangfuzi Health Recent Developments/Updates
Table 157. Kangfuzi Health Competitive Strengths & Weaknesses
Table 158. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System Upstream (Raw Materials)
Table 159. Global Multi-disease Fundus Imaging-assisted Diagnostic System Typical Customers
LIST OF FIGURES
Figure 1. Multi-disease Fundus Imaging-assisted Diagnostic System Picture
Figure 2. World Multi-disease Fundus Imaging-assisted Diagnostic System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Multi-disease Fundus Imaging-assisted Diagnostic System Total Revenue (2021-2032) & (USD Million)
Figure 4. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 13. Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 16. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 18. China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 23. India Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Multi-disease Fundus Imaging-assisted Diagnostic System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Multi-disease Fundus Imaging-assisted Diagnostic System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Multi-disease Fundus Imaging-assisted Diagnostic System Markets in 2025
Figure 27. United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Type in 2025
Figure 31. On-premise
Figure 32. Cloud-based
Figure 33. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Type (2021-2032)
Figure 34. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals, (USD Million), 2021 & 2025 & 2032
Figure 35. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Technology/Imaging Fundamentals in 2025
Figure 36. AI Based on Fundus Images
Figure 37. AI Based on OCT
Figure 38. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Technology/Imaging Fundamentals (2021-2032)
Figure 39. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions, (USD Million), 2021 & 2025 & 2032
Figure 40. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Core Functions in 2025
Figure 41. Disease Screening and Assisted Diagnosis Software
Figure 42. Systemic Health Risk Assessment Software
Figure 43. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Core Functions (2021-2032)
Figure 44. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes, (USD Million), 2021 & 2025 & 2032
Figure 45. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Deployment and Usage Modes in 2025
Figure 46. Embedded System Integrated into Professional Equipment
Figure 47. SaaS Service Based on Cloud Platform
Figure 48. Mobile/Portable Applications
Figure 49. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Deployment and Usage Modes (2021-2032)
Figure 50. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Application in 2025
Figure 52. Hospitals
Figure 53. Clinics
Figure 54. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Application (2021-2032)
Figure 55. Multi-disease Fundus Imaging-assisted Diagnostic System Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Multi-disease Fundus Imaging-assisted Diagnostic System Picture
Figure 2. World Multi-disease Fundus Imaging-assisted Diagnostic System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Multi-disease Fundus Imaging-assisted Diagnostic System Total Revenue (2021-2032) & (USD Million)
Figure 4. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2032) & (USD Million)
Figure 13. Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 16. World Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 18. China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 23. India Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Multi-disease Fundus Imaging-assisted Diagnostic System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Multi-disease Fundus Imaging-assisted Diagnostic System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Multi-disease Fundus Imaging-assisted Diagnostic System Markets in 2025
Figure 27. United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Type in 2025
Figure 31. On-premise
Figure 32. Cloud-based
Figure 33. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Type (2021-2032)
Figure 34. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals, (USD Million), 2021 & 2025 & 2032
Figure 35. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Technology/Imaging Fundamentals in 2025
Figure 36. AI Based on Fundus Images
Figure 37. AI Based on OCT
Figure 38. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Technology/Imaging Fundamentals (2021-2032)
Figure 39. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Core Functions, (USD Million), 2021 & 2025 & 2032
Figure 40. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Core Functions in 2025
Figure 41. Disease Screening and Assisted Diagnosis Software
Figure 42. Systemic Health Risk Assessment Software
Figure 43. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Core Functions (2021-2032)
Figure 44. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Deployment and Usage Modes, (USD Million), 2021 & 2025 & 2032
Figure 45. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Deployment and Usage Modes in 2025
Figure 46. Embedded System Integrated into Professional Equipment
Figure 47. SaaS Service Based on Cloud Platform
Figure 48. Mobile/Portable Applications
Figure 49. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Deployment and Usage Modes (2021-2032)
Figure 50. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Application in 2025
Figure 52. Hospitals
Figure 53. Clinics
Figure 54. World Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Market Share by Application (2021-2032)
Figure 55. Multi-disease Fundus Imaging-assisted Diagnostic System Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
